Search results
Results From The WOW.Com Content Network
Arena Pharmaceuticals, Inc. is an American biopharmaceutical company founded in 1997 and ... this was followed in July 2016 by the layoff of another 100 ...
Arena Pharmaceuticals (ARNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Arena Pharmaceuticals (ARNA) incurs wider-than-expected loss in the third quarter of 2019 while revenues beat estimates.
Arena Pharmaceuticals, Inc. (ARNA) delivered earnings and revenue surprises of -32.64% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ...
If you want to know who really controls Arena Pharmaceuticals, Inc. ( NASDAQ:ARNA ), then you'll have to look at the...
Arena (ARNA) inks a deal to out-license global rights to its phase III candidate, ralinepag, to United Therapeutics. Shares of the company rally 22% following this news.
What: Shares of obesity-fighting biotech Arena. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us ...
Let's look at Arena Pharmaceuticals (NAS: ARNA) today and Examine its pros and cons, and decide whether it's possible upside outweighs its risks. Buy, Sell, or Hold: Arena Pharmaceuticals